Drug
BRC-002
BRC-002 is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_1
2
67%
Ph phase_2
1
33%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting1
Enrolling by invitation1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 12 (66.7%)
Phase 21 (33.3%)
Trials by Status
recruiting133%
enrolling_by_invitation133%
not_yet_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
enrolling_by_invitationphase_1
Evaluation of BRC-002 Safety, Tolerability, Pharmacokinetics, and Food Effects in Healthy Participants
NCT07699120
not_yet_recruitingphase_2
Tolerability and Efficacy of CBD Extract for RLS Treatment
NCT07224932
recruitingphase_1
The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome
NCT06393101
Clinical Trials (3)
Showing 3 of 3 trials
NCT07699120Phase 1
Evaluation of BRC-002 Safety, Tolerability, Pharmacokinetics, and Food Effects in Healthy Participants
NCT07224932Phase 2
Tolerability and Efficacy of CBD Extract for RLS Treatment
NCT06393101Phase 1
The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3